Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Jun 21;91(13):5868–5872. doi: 10.1073/pnas.91.13.5868

Disulfide linkages in the in vitro refolded intermediates of recombinant human macrophage-colony-stimulating factor: analysis of the sulfhydryl alkylation of free cysteine residues by fast-atom bombardment mass spectrometry.

M O Glocker 1, B Arbogast 1, R Milley 1, C Cowgill 1, M L Deinzer 1
PMCID: PMC44098  PMID: 8016080

Abstract

Fast-atom bombardment mass spectrometry was used to follow the time course of disulfide bond formation during in vitro refolding of recombinant human macrophage-colony-stimulating factor. The content of iodoacetamide-alkylated half-cystines in proteolytic peptides of trapped refolding intermediates collected at 0, 6, 17, 24, and 72 hr was determined under reducing conditions. Size-exclusion high-performance liquid chromatography analyses of the collected alkylated samples indicate that aggregated monomer proceeded through a nonaggregated monomer to an intermediate dimer and finally to the fully folded and active dimer. Underalkylation was first detected by fast-atom bombardment mass spectrometry in 17-hr samples at Cys157 and Cys159 and this corresponded to the first sample containing dimer. Analyses of intermediates from subsequent time points indicated a decrease in alkylated sulfhydryls, and at 72 hr no alkylated peptide was detected. Early samples containing only monomer showed no evidence of disulfide bonds, and the occurrence of disulfide shuffling at the monomer stage could be ruled out under the highly reducing conditions used for refolding. Biological activity was not detectable in early samples but increased to 3.6% after 24 hr of refolding and to 86% of maximum at the 72-hr time point.

Full text

PDF
5868

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggarwal B. B., Pocsik E. Cytokines: from clone to clinic. Arch Biochem Biophys. 1992 Feb 1;292(2):335–359. doi: 10.1016/0003-9861(92)90002-e. [DOI] [PubMed] [Google Scholar]
  2. Cerretti D. P., Wignall J., Anderson D., Tushinski R. J., Gallis B. M., Stya M., Gillis S., Urdal D. L., Cosman D. Human macrophage-colony stimulating factor: alternative RNA and protein processing from a single gene. Mol Immunol. 1988 Aug;25(8):761–770. doi: 10.1016/0161-5890(88)90112-5. [DOI] [PubMed] [Google Scholar]
  3. Clark S. C., Kamen R. The human hematopoietic colony-stimulating factors. Science. 1987 Jun 5;236(4806):1229–1237. doi: 10.1126/science.3296190. [DOI] [PubMed] [Google Scholar]
  4. Creighton T. E. Disulfide bond formation in proteins. Methods Enzymol. 1984;107:305–329. doi: 10.1016/0076-6879(84)07021-x. [DOI] [PubMed] [Google Scholar]
  5. Glocker M. O., Arbogast B., Schreurs J., Deinzer M. L. Assignment of the inter- and intramolecular disulfide linkages in recombinant human macrophage colony stimulating factor using fast atom bombardment mass spectrometry. Biochemistry. 1993 Jan 19;32(2):482–488. doi: 10.1021/bi00053a012. [DOI] [PubMed] [Google Scholar]
  6. Kawasaki E. S., Ladner M. B. Molecular biology of macrophage colony-stimulating factor. Immunol Ser. 1990;49:155–176. [PubMed] [Google Scholar]
  7. Morris H. R., Pucci P. A new method for rapid assignment of S-S bridges in proteins. Biochem Biophys Res Commun. 1985 Feb 15;126(3):1122–1128. doi: 10.1016/0006-291x(85)90302-x. [DOI] [PubMed] [Google Scholar]
  8. Morris H. R., Pucci P., Panico M., Marino G. Protein folding/refolding analysis by mass spectrometry. Scrambling of disulphide bridges in insulin. Biochem J. 1990 Jun 15;268(3):803–806. doi: 10.1042/bj2680803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nakoinz I., Lee M. T., Weaver J. F., Ralph P. Differentiation of the IL-3-dependent NFS-60 cell line and adaption to growth in macrophage colony-stimulating factor. J Immunol. 1990 Aug 1;145(3):860–864. [PubMed] [Google Scholar]
  10. Nemunaitis J., Meyers J. D., Buckner C. D., Shannon-Dorcy K., Mori M., Shulman H., Bianco J. A., Higano C. S., Groves E., Storb R. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood. 1991 Aug 15;78(4):907–913. [PubMed] [Google Scholar]
  11. Pandit J., Bohm A., Jancarik J., Halenbeck R., Koths K., Kim S. H. Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. Science. 1992 Nov 20;258(5086):1358–1362. doi: 10.1126/science.1455231. [DOI] [PubMed] [Google Scholar]
  12. Suckau D., Shi Y., Beu S. C., Senko M. W., Quinn J. P., Wampler F. M., 3rd, McLafferty F. W. Coexisting stable conformations of gaseous protein ions. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):790–793. doi: 10.1073/pnas.90.3.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wilkins J. A., Cone J., Randhawa Z. I., Wood D., Warren M. K., Witkowska H. E. A study of intermediates involved in the folding pathway for recombinant human macrophage colony-stimulating factor (M-CSF): evidence for two distinct folding pathways. Protein Sci. 1993 Feb;2(2):244–254. doi: 10.1002/pro.5560020213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Yazdanparast R., Andrews P. C., Smith D. L., Dixon J. E. Assignment of disulfide bonds in proteins by fast atom bombardment mass spectrometry. J Biol Chem. 1987 Feb 25;262(6):2507–2513. [PubMed] [Google Scholar]
  15. Yazdanparast R., Andrews P., Smith D. L., Dixon J. E. A new approach for detection and assignment of disulfide bonds in peptides. Anal Biochem. 1986 Mar;153(2):348–353. doi: 10.1016/0003-2697(86)90102-8. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES